Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Journal of Clinical Pharmacology|August 16, 2024
Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological ProductsBrianna Eales, Nada A Helal, Olivia Vattelana, et al.
Frontiers in Pediatrics|November 4, 2021
Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?Xiaomei I Liu, Dionna J Green, John N van den Anker, et al.
Clinical Pharmacology and Therapeutics|May 13, 2020
Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018Irin Tanaudommongkon, Shogo John Miyagi, Dionna J Green, et al.
The Journal of Pediatrics|January 26, 2019
A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug AdministrationXiaomei I Liu, Paul Schuette, Gilbert J Burckart, et al.
The AAPS Journal|March 10, 2026
PQRI Workshop: Model-Informed Drug Development (MIDD) Approaches in Pediatric Formulation DevelopmentGilbert J Burckart, Susan Abdel-Rahman, Caleb Choi, et al.
Journal of Clinical Pharmacology|September 7, 2019
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and AcyclovirXiaomei I Liu, Jeremiah D Momper, Natella Rakhmanina, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 12, 2004
Interleukin-10 production genotype protects against acute persistent rejection after lung transplantationHong Xia Zheng, Gilbert J Burckart, Kenneth McCurry, et al.
Journal of Clinical Pharmacology|April 18, 2018
Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDADionna J Green, Janelle M Burnham, Paul Schuette, et al.
Clinical Pharmacokinetics|February 2, 2021
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, et al.
Clinical Pharmacology and Therapeutics|January 7, 2021
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee MeetingMartina D Sahre, Lauren Milligan, Rajanikanth Madabushi, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Journal of Clinical Pharmacology|August 16, 2024
Population Pharmacokinetics (PopPK) Support for Pediatric Dosing of Biological ProductsBrianna Eales, Nada A Helal, Olivia Vattelana, et al.
Frontiers in Pediatrics|November 4, 2021
Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?Xiaomei I Liu, Dionna J Green, John N van den Anker, et al.
Clinical Pharmacology and Therapeutics|May 13, 2020
Combined Pediatric and Adult Trials Submitted to the US Food and Drug Administration 2012-2018Irin Tanaudommongkon, Shogo John Miyagi, Dionna J Green, et al.
The Journal of Pediatrics|January 26, 2019
A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug AdministrationXiaomei I Liu, Paul Schuette, Gilbert J Burckart, et al.
The AAPS Journal|March 10, 2026
PQRI Workshop: Model-Informed Drug Development (MIDD) Approaches in Pediatric Formulation DevelopmentGilbert J Burckart, Susan Abdel-Rahman, Caleb Choi, et al.
Journal of Clinical Pharmacology|September 7, 2019
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and AcyclovirXiaomei I Liu, Jeremiah D Momper, Natella Rakhmanina, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 12, 2004
Interleukin-10 production genotype protects against acute persistent rejection after lung transplantationHong Xia Zheng, Gilbert J Burckart, Kenneth McCurry, et al.
Journal of Clinical Pharmacology|April 18, 2018
Primary Endpoints in Pediatric Efficacy Trials Submitted to the US FDADionna J Green, Janelle M Burnham, Paul Schuette, et al.
Clinical Pharmacokinetics|February 2, 2021
Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and RaltegravirXiaomei I Liu, Jeremiah D Momper, Natella Y Rakhmanina, et al.
Clinical Pharmacology and Therapeutics|January 7, 2021
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee MeetingMartina D Sahre, Lauren Milligan, Rajanikanth Madabushi, et al.
Pageof 13